Back
BioXcel Therapeutics Vs. Griffon Industry Stock Comparison
Sell
37
BTAI
BioXcel Therapeutics
Last Price:
0.53
Seasonality Move:
80.1%
Buy
70
GFF
Griffon
Last Price:
77.30
Seasonality Move:
14.29%
Sell
37
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $0.62. The Score for BTAI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Griffon (GFF)
is a Buy
Is Griffon a Buy, Sell or Hold?
- The current Griffon [GFF] share price is $80.52. The Score for GFF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- GFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $0.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight selling pressure.
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 47.27 | Sell |
| Chaikin Money Flow: | -240821 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.68) | Sell |
| Bollinger Bands (100): | (0.53 - 1.05) | Sell |
GFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.42 | Buy |
| Relative Strength Index (14 RSI): | 78.19 | Buy |
| Chaikin Money Flow: | 1692432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.12 - 70.34) | Buy |
| Bollinger Bands (100): | (62.68 - 70.2) | Buy |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.68 | Sell |
| 20-day SMA: | 0.64 | Sell |
| 50-day SMA: | 0.6 | Buy |
| 200-day SMA: | 1.67 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 2.08 | Sell |
GFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.94 | Buy |
| 20-day SMA: | 66.4 | Buy |
| 50-day SMA: | 66.92 | Buy |
| 200-day SMA: | 67.26 | Buy |
| 8-day EMA: | 70.29 | Buy |
| 20-day EMA: | 67.85 | Buy |
| 50-day EMA: | 67.02 | Buy |
| 200-day EMA: | 63.95 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.99 per share, and an increase next year of $0.47 per share.
Griffon Earnings Growth & GFF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.76 per share.
BioXcel Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Griffon Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||